Abstract
Gene–environment interactions have been traditionally understood to promote the acquisition of mutations that drive multistage carcinogenesis, and, in the case of inherited defects in tumour suppressor genes, additional mutations are required for cancer development. However, the developmental origins of health and disease (DOHAD) hypothesis provides an alternative model whereby environmental exposures during development increase susceptibility to cancer in adulthood, not by inducing genetic mutations, but by reprogramming the epigenome. We hypothesize that this epigenetic reprogramming functions as a new type of gene–environment interaction by which environmental exposures target the epigenome to increase cancer susceptibility.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Change history
04 July 2012
This has been corrected on both html and pdf versions.
References
Reuben, S. H. in 2008–2009 Annual Report, President's Cancer Panel (National Institutes of Health; National Cancer Institute, 2010) [online]
Campeau, P. M., Foulkes, W. D. & Tischkowitz, M. D. Hereditary breast cancer: new genetic developments, new therapeutic avenues. Hum. Genet. 124, 31–42 (2008).
Danaei, G., Vander Hoorn, S., Lopez, A. D., Murray, C. J. & Ezzati, M. Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet 366, 1784–1793 (2005).
Wilson, S., Jones, L. A., Couseens, C. & Hanna, K. Cancer and the Environment: Gene-Environment Interactions. (National Academies Press, 2002).
King, M. C., Marks, J. H. & Mandell, J. B. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302, 643–646 (2003).
Shuen, A. Y. & Foulkes, W. D. Inherited mutations in breast cancer genes--risk and response. J. Mammary Gland Biol. Neoplasia 16, 3–15 (2011).
Gillman, M. W. Developmental origins of health and disease. N. Engl. J. Med. 353, 1848–1850 (2005).
Barker, D. J. Developmental origins of chronic disease. Public Health 126, 185–189 (2012).
Finnell, R. H., Waes, J. G., Eudy, J. D. & Rosenquist, T. H. Molecular basis of environmentally induced birth defects. Annu. Rev. Pharmacol. Toxicol. 42, 181–208 (2002).
Swanson, J. M., Entringer, S., Buss, C. & Wadhwa, P. D. Developmental origins of health and disease: environmental exposures. Semin. Reprod. Med. 27, 391–402 (2009).
Ravelli, G. P., Stein, Z. A. & Susser, M. W. Obesity in young men after famine exposure in utero and early infancy. N. Engl. J. Med. 295, 349–353 (1976).
Roseboom, T. J. et al. Effects of prenatal exposure to the Dutch famine on adult disease in later life: an overview. Mol. Cell Endocrinol. 185, 93–98 (2001).
Painter, R. C., Roseboom, T. J. & Bleker, O. P. Prenatal exposure to the Dutch famine and disease in later life: an overview. Reprod. Toxicol. 20, 345–352 (2005).
Roseboom, T. J. Undernutrition during fetal life and the risk of cardiovascular disease in adulthood. Future Cardiol 8, 5–7 (2012).
Barker, D. J. P. Mothers, Babies, and Disease in Later Life. (BMJ Publishing, 1994).
Stein, A. D., Zybert, P. A., van de Bor, M. & Lumey, L. H. Intrauterine famine exposure and body proportions at birth: the Dutch Hunger Winter. Int. J. Epidemiol. 33, 831–836 (2004).
Morley, R., Owens, J., Blair, E. & Dwyer, T. Is birthweight a good marker for gestational exposures that increase the risk of adult disease? Paediatr. Perinat Epidemiol. 16, 194–199 (2002).
Ravelli, A. C., van Der Meulen, J. H., Osmond, C., Barker, D. J. & Bleker, O. P. Obesity at the age of 50 y in men and women exposed to famine prenatally. Am. J. Clin. Nutr. 70, 811–816 (1999).
Berdasco, M. & Esteller, M. Aberrant epigenetic landscape in cancer: how cellular identity goes awry. Dev. Cell 19, 698–711 (2010).
Ruthenburg, A. J., Li, H., Patel, D. J. & Allis, C. D. Multivalent engagement of chromatin modifications by linked binding modules. Nature Rev. Mol. Cell Biol. 8, 983–994 (2007).
Zhao, Q. et al. PRMT5-mediated methylation of histone H4R3 recruits DNMT3A, coupling histone and DNA methylation in gene silencing. Nature Struct. Mol. Biol. 16, 304–311 (2009).
Vire, E. et al. The Polycomb group protein EZH2 directly controls DNA methylation. Nature 439, 871–874 (2006).
Smallwood, A., Esteve, P. O., Pradhan, S. & Carey, M. Functional cooperation between HP1 and DNMT1 mediates gene silencing. Genes Dev. 21, 1169–1178 (2007).
Bannister, A. J. et al. Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain. Nature 410, 120–124 (2001).
Lachner, M., O'Carroll, D., Rea, S., Mechtler, K. & Jenuwein, T. Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature 410, 116–120 (2001).
Aguilera, O., Fernandez, A. F., Munoz, A. & Fraga, M. F. Epigenetics and environment: a complex relationship. J. Appl. Physiol. 109, 243–251 (2010).
Baylin, S. B. & Jones, P. A. A decade of exploring the cancer epigenome - biological and translational implications. Nature Rev. Cancer 11, 726–734 (2011).
Tobi, E. W. et al. DNA methylation differences after exposure to prenatal famine are common and timing- and sex-specific. Hum. Mol. Genet. 18, 4046–4053 (2009).
Waterland, R. A. et al. Season of conception in rural gambia affects DNA methylation at putative human metastable epialleles. PLoS Genet. 6, e1001252 (2010).
Soshnikova, N. & Duboule, D. Epigenetic regulation of Hox gene activation: the waltz of methyls. Bioessays 30, 199–202 (2008).
Hales, C. N. & Barker, D. J. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia 35, 595–601 (1992).
Tang, W. Y. et al. Persistent hypomethylation in the promoter of nucleosomal binding protein 1 (Nsbp1) correlates with overexpression of Nsbp1 in mouse uteri neonatally exposed to diethylstilbestrol or genistein. Endocrinology 149, 5922–5931 (2008).
Li, S. et al. Developmental exposure to diethylstilbestrol elicits demethylation of estrogen-responsive lactoferrin gene in mouse uterus. Cancer Res. 57, 4356–4359 (1997).
Jirtle, R. L. & Skinner, M. K. Environmental epigenomics and disease susceptibility. Nature Rev. Genet. 8, 253–262 (2007).
Steegers-Theunissen, R. P. et al. Periconceptional maternal folic acid use of 400 microg per day is related to increased methylation of the IGF2 gene in the very young child. PLoS ONE 4, e7845 (2009).
Choi, S. W. & Friso, S. Epigenetics: a new bridge between nutrition and health. Adv. Nutr. 1, 8–16 (2010).
McLachlan, J. A., Burow, M., Chiang, T. C. & Li, S. F. Gene imprinting in developmental toxicology: a possible interface between physiology and pathology. Toxicol. Lett. 120, 161–164 (2001).
Li, S. et al. Neonatal diethylstilbestrol exposure induces persistent elevation of c-fos expression and hypomethylation in its exon-4 in mouse uterus. Mol. Carcinog. 38, 78–84 (2003).
Bromer, J. G., Wu, J., Zhou, Y. & Taylor, H. S. Hypermethylation of homeobox A10 by in utero diethylstilbestrol exposure: an epigenetic mechanism for altered developmental programming. Endocrinology 150, 3376–3382 (2009).
Ho, S. M., Tang, W. Y., Belmonte de Frausto, J. & Prins, G. S. Developmental exposure to estradiol and bisphenol A increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase type 4 variant 4. Cancer Res. 66, 5624–5632 (2006).
Bromer, J. G., Zhou, Y., Taylor, M. B., Doherty, L. & Taylor, H. S. Bisphenol-A exposure in utero leads to epigenetic alterations in the developmental programming of uterine estrogen response. Faseb J. 24, 2273–2280 (2010).
Cook, J. D. et al. Interaction between genetic susceptibility and early-life environmental exposure determines tumor-suppressor-gene penetrance. Proc. Natl Acad. Sci. USA 102, 8644–8649 (2005).
Greathouse, K. L. et al. Identification of uterine leiomyoma genes developmentally reprogrammed by neonatal exposure to diethylstilbestrol. Reprod. Sci. 15, 765–778 (2008).
Trichopoulos, D. Hypothesis: does breast cancer originate in utero? Lancet 335, 939–940 (1990).
Troisi, R., Potischman, N. & Hoover, R. N. Exploring the underlying hormonal mechanisms of prenatal risk factors for breast cancer: a review and commentary. Cancer Epidemiol. Biomarkers Prev. 16, 1700–1712 (2007).
Xue, F. & Michels, K. B. Intrauterine factors and risk of breast cancer: a systematic review and meta-analysis of current evidence. Lancet Oncol. 8, 1088–1100 (2007).
Barker, D. J., Osmond, C., Thornburg, K. L., Kajantie, E. & Eriksson, J. G. A possible link between the pubertal growth of girls and ovarian cancer in their daughters. Am. J. Hum. Biol. 20, 659–662 (2008).
Barker, D. J., Osmond, C., Thornburg, K. L., Kajantie, E. & Eriksson, J. G. A possible link between the pubertal growth of girls and prostate cancer in their sons. Am. J. Hum. Biol. 27 Jan 2012 (doi:10.1002/ajhb.22222).
Eriksson, M. et al. The impact of birth weight on prostate cancer incidence and mortality in a population-based study of men born in 1913 and followed up from 50 to 85 years of age. Prostate 67, 1247–1254 (2007).
Nilsen, T. I., Romundstad, P. R., Troisi, R. & Vatten, L. J. Birth size and subsequent risk for prostate cancer: a prospective population-based study in Norway. Int. J. Cancer 113, 1002–1004 (2005).
Platz, E. A. et al. Retrospective analysis of birth weight and prostate cancer in the health professionals follow-up study. Am. J. Epidemiol. 147, 1140–1144 (1998).
Rohrmann, S. et al. Racial variation in sex steroid hormones and the insulin-like growth factor axis in umbilical cord blood of male neonates. Cancer Epidemiol. Biomarkers Prev. 18, 1484–1491 (2009).
Barker, D. J., Thornburg, K. L., Osmond, C., Kajantie, E. & Eriksson, J. G. The prenatal origins of lung cancer. II. The placenta. Am. J. Hum. Biol. 22, 512–516 (2010).
Eriksson, J. G., Thornburg, K. L., Osmond, C., Kajantie, E. & Barker, D. J. The prenatal origins of lung cancer. I. The fetus. Am. J. Hum. Biol. 22, 508–511 (2010).
Herbst, A. L., Ulfelder, H. & Poskanzer, D. C. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N. Engl. J. Med. 284, 878–881 (1971).
Baird, D. D. & Newbold, R. Prenatal diethylstilbestrol (DES) exposure is associated with uterine leiomyoma development. Reprod. Toxicol. 20, 81–84 (2005).
Palmer, J. R. et al. Prenatal diethylstilbestrol exposure and risk of breast cancer. Cancer Epidemiol. Biomarkers Prev. 15, 1509–1514 (2006).
Verloop, J., van Leeuwen, F. E., Helmerhorst, T. J., van Boven, H. H. & Rookus, M. A. Cancer risk in DES daughters. Cancer Causes Control 21, 999–1007 (2010).
Wise, L. A. et al. Risk of benign gynecologic tumors in relation to prenatal diethylstilbestrol exposure. Obstet. Gynecol. 105, 167–173 (2005).
Schrager, S. & Potter, B. E. Diethylstilbestrol exposure. Am. Fam Physician 69, 2395–2400 (2004).
Newbold, R. R., Hanson, R. B. & Jefferson, W. N. Ontogeny of lactoferrin in the developing mouse uterus: a marker of early hormone response. Biol. Reprod. 56, 1147–1157 (1997).
Newbold, R. R., Bullock, B. C. & McLachlan, J. A. Uterine adenocarcinoma in mice following developmental treatment with estrogens: a model for hormonal carcinogenesis. Cancer Res. 50, 7677–7681 (1990).
Walker, C. L. & Stewart, E. A. Uterine fibroids: the elephant in the room. Science 308, 1589–1592 (2005).
McCampbell, A. S., Walker, C. L., Broaddus, R. R., Cook, J. D. & Davies, P. J. Developmental reprogramming of IGF signaling and susceptibility to endometrial hyperplasia in the rat. Lab. Invest. 88, 615–626 (2008).
McCampbell, A. S., Broaddus, R. R. & Walker, C. L. Loss of inhibitory insulin receptor substrate-1 phosphorylation: An early event in endometrial hyperplasia and progression to carcinoma. Cell Cycle 9, 2698–2699 (2010).
Rudel, R. A., Fenton, S. E., Ackerman, J. M., Euling, S. Y. & Makris, S. L. Environmental exposures and mammary gland development: state of the science, public health implications, and research recommendations. Environ. Health Perspect. 119, 1053–1061 (2011).
Russo, J. & Russo, I. H. Breast development, hormones and cancer. Adv. Exp. Med. Biol. 630, 52–56 (2008).
De Assis, S. & Hilakivi-Clarke, L. Timing of dietary estrogenic exposures and breast cancer risk. Ann. NY Acad. Sci. 1089, 14–35 (2006).
Painter, R. C. et al. A possible link between prenatal exposure to famine and breast cancer: a preliminary study. Am. J. Hum. Biol. 18, 853–856 (2006).
Skakkebaek, N. E., Rajpert-De Meyts, E. & Main, K. M. Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum. Reprod. 16, 972–978 (2001).
Sharpe, R. M. & Skakkebaek, N. E. Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract? Lancet 341, 1392–1395 (1993).
Sonne, S. B. et al. Analysis of gene expression profiles of microdissected cell populations indicates that testicular carcinoma in situ is an arrested gonocyte. Cancer Res. 69, 5241–5250 (2009).
Almstrup, K. et al. Carcinoma in situ testis displays permissive chromatin modifications similar to immature foetal germ cells. Br. J. Cancer 103, 1269–1276 (2010).
Dusek, L. et al. Multivariate analysis of risk factors for testicular cancer: a hospital-based case-control study in the Czech Republic. Neoplasma 55, 356–368 (2008).
Hjalgrim, L. L. et al. Birth weight as a risk factor for childhood leukemia: a meta-analysis of 18 epidemiologic studies. Am. J. Epidemiol. 158, 724–735 (2003).
Newbold, R. R., Bullock, B. C. & McLachlan, J. A. Adenocarcinoma of the rete testis. Diethylstilbestrol-induced lesions of the mouse rete testis. Am. J. Pathol. 125, 625–628 (1986).
Newbold, R. R., Bullock, B. C. & McLachlan, J. A. Testicular tumors in mice exposed in utero to diethylstilbestrol. J. Urol. 138, 1446–1450 (1987).
Prins, G. S. Endocrine disruptors and prostate cancer risk. Endocr. Relat Cancer 15, 649–656 (2008).
Bredfeldt, T. G. et al. Xenoestrogen-induced regulation of EZH2 and histone methylation via estrogen receptor signaling to PI3K/AKT. Mol. Endocrinol. 24, 993–1006 (2010).
Simon, J. A. & Lange, C. A. Roles of the EZH2 histone methyltransferase in cancer epigenetics. Mutat. Res. 647, 21–29 (2008).
Cook, J. D., Davis, B. J., Goewey, J. A., Berry, T. D. & Walker, C. L. Identification of a sensitive period for developmental programming that increases risk for uterine leiomyoma in Eker rats. Reprod. Sci. 14, 121–136 (2007).
Soto, A. M., Vandenberg, L. N., Maffini, M. V. & Sonnenschein, C. Does breast cancer start in the womb? Basic Clin. Pharmacol. Toxicol. 102, 125–133 (2008).
Acknowledgements
C.L.W. is supported by grants from the US National Institutes of Health (ES018789, ES008263 and ES020055) and the Cancer Prevention and Research Institute of Texas (CPRIT RP120855). S.-M.H. is supported by grants from the NIH (P30ES006096, U01ES019480, R01ES015584, RC2ES018758 and RC2ES018789) and a VA award (I01BX000675).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Related links
FURTHER INFORMATION
Rights and permissions
About this article
Cite this article
Walker, C., Ho, Sm. Developmental reprogramming of cancer susceptibility. Nat Rev Cancer 12, 479–486 (2012). https://doi.org/10.1038/nrc3220
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrc3220
This article is cited by
-
Exposure to Endocrine-Disrupting Chemicals and Type 2 Diabetes Mellitus in Later Life
Exposure and Health (2023)
-
Biotechnology-based microbial degradation of plastic additives
3 Biotech (2021)
-
Epigenome environment interactions accelerate epigenomic aging and unlock metabolically restricted epigenetic reprogramming in adulthood
Nature Communications (2020)
-
Reversal of increased mammary tumorigenesis by valproic acid and hydralazine in offspring of dams fed high fat diet during pregnancy
Scientific Reports (2019)
-
Chemically induced carcinogenesis in rodent models of aging: assessing organismal resilience to genotoxic stressors in geroscience research
GeroScience (2019)